Immunological patterns identifying disease course and evolution in multiple sclerosis patients

被引:35
作者
Furlan, R
Rovaris, M
Boneschi, FM
Khademi, M
Bergami, A
Gironi, M
Deleidi, M
Agosta, F
Franciotta, D
Scarpini, E
Uccelli, A
Zaffaroni, M
Kurne, A
Comi, G
Olsson, T
Filippi, M
Martino, G
机构
[1] Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Neuroimaging Res Unit, I-20132 Milan, Italy
[4] Karolinska Hosp, Neuroimmunol Unit, S-17176 Stockholm, Sweden
[5] IRCCS Fdn Ist Neurol C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy
[6] Univ Milan, IRCCS, Osped Maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy
[7] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Neuroimmunol Unit, I-16132 Genoa, Italy
[8] S Antonio Abate Hosp, Multiple Sclerosis Ctr, I-21013 Gallarate, VA, Italy
关键词
multiple sclerosis; chemokines; cytokines; real-time RT-PCR; multivariate analysis;
D O I
10.1016/j.jneuroim.2005.04.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multiple sclerosis (MS) patients are still lacking. We applied a multivariate statistical analysis on results obtained by measuring-by real-time RT-PCR-mRNA levels of 25 immunological relevant molecules in PBMCs from 198 MS patients. The combined measurement of mRNA levels of IL-1 beta, TNF-alpha, TGF-beta, CCL20 and CCR3 was able to distinguish MS patients from healthy individuals. CXCR5, CCL5, and CCR3 combined mRNA levels identify primary progressive MS patients while TNF-alpha, IL-10, CXCL10 and CCR3 differentiate relapsing MS patients. Our results indicate that multi-parametric analysis of mRNA levels of immunological relevant molecules in PBMCs may represent a successful strategy for the identification of putative peripheral markers of disease state and disease activity in MS patients. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:192 / 200
页数:9
相关论文
共 41 条
[1]   Intrathecal sICAM-1 production in multiple sclerosis -: Correlation with triple dose Gd-DTPA MRI enhancement and IgG index [J].
Acar, G ;
Idiman, F ;
Kirkali, G ;
Özakbas, S ;
Oktay, G ;
Çakmakçi, H ;
Idiman, E .
JOURNAL OF NEUROLOGY, 2005, 252 (02) :146-150
[2]   Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro [J].
Ambrosini, E ;
Columba-Cabezas, S ;
Serafini, B ;
Muscella, A ;
Aloisi, F .
GLIA, 2003, 41 (03) :290-300
[3]   Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[4]   Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis [J].
Eikelenboom, MJ ;
Killestein, J ;
Izeboud, T ;
Kalkers, NF ;
van Lier, RAW ;
Barkhof, F ;
Uitdehaag, BMJ ;
Polman, CH .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) :225-232
[5]   Predictive value of MRI findings in multiple sclerosis [J].
Filippi, M .
LANCET NEUROLOGY, 2002, 1 (01) :9-9
[6]   Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies [J].
Franciotta, D ;
Martino, G ;
Zardini, E ;
Furlan, R ;
Bergamaschi, R ;
Andreoni, L ;
Cosi, V .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 115 (1-2) :192-198
[7]   Immunological indicators of disease activity and prognosis in multiple sclerosis [J].
Galboiz, Y ;
Miller, A .
CURRENT OPINION IN NEUROLOGY, 2002, 15 (03) :233-237
[8]   Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS [J].
Giunti, D ;
Borsellino, G ;
Benelli, R ;
Marchese, M ;
Capello, E ;
Valle, MT ;
Pedemonte, E ;
Noonan, D ;
Albini, A ;
Bernardi, G ;
Mancardi, GL ;
Battistini, L ;
Uccelli, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (05) :584-590
[9]   New concepts in the immunopathogenesis of multiple sclerosis [J].
Hemmer, B ;
Archelos, JJ ;
Hartung, HP .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (04) :291-301
[10]   Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes [J].
Jalonen, TO ;
Pulkkinen, K ;
Ukkonen, M ;
Saarela, M ;
Elovaara, I .
JOURNAL OF NEUROLOGY, 2002, 249 (05) :576-583